Tagged with Latin America

Pharma John Fernández van Cleve, Chancellor of UPRM, highlights the institution’s strong expertise in engineering and its application in the pharmaceutical and medical device fields. What are some of UPRM’s main assets? We are very blessed to have the best students in Puerto Rico. UPRM’s admission index is the highest on…

Philips PharmaBoardroom briefly met up with Henk de Jong, CEO of Philips Latin America at the Financial Times LatAm Healthcare & Life Sciences Summit in Miami in September 2015. He discusses the importance of the Philips brand for both its consumer and healthcare divisions. You have a long history working in…

life sciences John Taboas is the president of Biopharma Consulting Services (BCS), a leader in visual inspection and other validation and engineering services. Here he tells PharmaBoardroom how the company is working to position Puerto Rico as a hub for subject matter experts in visual inspection, with a new training facility and inspection…

Puerto Rico Puerto Rico’s healthcare insurance market is the first in Latin America in terms of penetration and sixth in terms of premium volume. Ángela Weyne, Insurance Commissioner of Puerto Rico, discusses how recent amendments to the Affordable Care Act (ACA) have been implemented locally, how she is spurring healthy competition among…

Aldimed As a means of introduction, could you please describe the origins of ALDIMED, how it started, its development the past couple of years and where it stands today? ALDIMED represents the medical technology industry in Latin America; this is a Colombian initiative and one of its founders. The Executive Board…

Brazil In an exclusive interview, Otto Philipp Braun, part of medtech giant B. Braun’s family dynasty, discusses his achievements as MD in Brazil, the company’s operations in the country and globally, as well as its CSR programs. B. Braun has been established in Brazil for more than 40 years, with its headquarters…

Nycomed Latin America The executive management of Nycomed said in an interview that ‘the tremendous growth of the pharmaceutical industry will not occur in either Europe or the United States, but in emerging economies such as Latin America.’ What is the relative importance of Nycomed Latin America for the company from a global…